Dendreon is a commercial-stage biopharmaceutical company specializing in immunotherapy. The company is best known for PROVENGE (sipuleucel-T), the first FDA-approved immunotherapy made from a patient's own immune cells, which has been prescribed to over 40,000 men with advanced prostate cancer since 2010. Dendreon also explores the use of PROVENGE in early-stage prostate cancer and offers contract manufacturing services.
Dendreon is seeking a Strategic Account Manager to execute within community-based and targeted hospital accounts, focusing on high value urology and oncology accounts. The role requires a total coverage mindset, proactiveness, leadership, and PROVENGE subject matter expertise.
Dendreon is a commercial-stage biopharmaceutical company specializing in immunotherapy. The company is best known for PROVENGE (sipuleucel-T), the first FDA-approved immunotherapy made from a patient's own immune cells, which has been prescribed to over 40,000 men with advanced prostate cancer since 2010. Dendreon also explores the use of PROVENGE in early-stage prostate cancer and offers contract manufacturing services.